Showing 161 - 180 results of 15,798 for search '(( significant gap decrease ) OR ( significantly linked increase ))', query time: 0.45s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168

    Classes of errors and gaps in BOLD metadata. by Frederik Stein (22146203)

    Published 2025
    “…ASAP was found to be superior to RESL due to RESL’s adherence to the concept of the DNA barcoding gap. Moreover, we found that taxonomic misassignments, inconsistencies in BIN formation, and missing metadata also contribute significantly to unreliable identifications. …”
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175

    Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

    Published 2024
    “…The 15 gene sets identified as significant by EGSEA for Cholesterol contain 40 unique genes. …”
  16. 176
  17. 177

    Image_3_The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.jpeg by Polina Pyatilova (13153977)

    Published 2022
    “…Increased numbers of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells were not associated with clinical and laboratory features of ISM, including disease burden, symptom severity, evidence of anaphylaxis, and tryptase levels.…”
  18. 178

    Table_2_The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.docx by Polina Pyatilova (13153977)

    Published 2022
    “…Increased numbers of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells were not associated with clinical and laboratory features of ISM, including disease burden, symptom severity, evidence of anaphylaxis, and tryptase levels.…”
  19. 179

    Image_1_The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.jpeg by Polina Pyatilova (13153977)

    Published 2022
    “…Increased numbers of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells were not associated with clinical and laboratory features of ISM, including disease burden, symptom severity, evidence of anaphylaxis, and tryptase levels.…”
  20. 180

    Table_1_The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity.docx by Polina Pyatilova (13153977)

    Published 2022
    “…Increased numbers of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells were not associated with clinical and laboratory features of ISM, including disease burden, symptom severity, evidence of anaphylaxis, and tryptase levels.…”